BeOne Medicines AG
ONC | NASDAQ
$387.25
+$9.47 (+2.51%)
At close: Nov 5, 2026, 4:00 PM ET
$380.00
-$7.25 (-1.87%)
After-hours:
Nov 5, 2026, 5:12 PM ET
Fiscal Year Period Ending | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 | FY 2020 Dec 31, 2020 |
|---|---|---|---|---|---|---|
Revenue | 5.34B | 3.81B | 2.46B | 1.42B | 1.18B | 308.87M |
Cost of Revenue | 668.54M | 594.09M | 379.92M | 286.48M | 164.91M | 70.66M |
Gross Profit | 4.67B | 3.22B | 2.08B | 1.13B | 1.01B | 238.22M |
Operating Income | 447.14M | -568.2M | -1.21B | -1.79B | -1.44B | -1.66B |
Interest Income | 70.51M | 47.84M | 74.01M | 52.48M | 15.76M | 2M |
Pretax Income | 416.85M | -533M | -825.84M | -1.96B | -1.44B | -1.62B |
Net Income | 286.93M | -644.79M | -881.71M | -2B | -1.46B | -1.62B |
Selling & General & Admin | 2.08B | 1.83B | 1.51B | 1.28B | 990.12M | 600.18M |
Research & Development | 2.15B | 1.95B | 1.78B | 1.64B | 1.46B | 1.29B |
Other Expenses | n/a | n/a | n/a | n/a | 750K | 846K |
Operating Expenses | 4.23B | 3.78B | 3.29B | 2.92B | 2.45B | 1.9B |
Interest Expense | 58.23M | n/a | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 4.9B | 4.38B | 3.67B | 3.21B | 2.62B | 1.97B |
Income Tax Expense | 129.92M | 111.79M | 55.87M | 42.78M | 19.23M | 10.4M |
Shares Outstanding (Basic) | 109.06M | 105.29M | 104.39M | 103.13M | 92.79M | 83.47M |
Shares Outstanding (Diluted) | 113.45M | 105.29M | 104.39M | 103.13M | 92.79M | 83.47M |
EPS (Basic) | 33.80 | -6.12 | -8.45 | -19.37 | -15.21 | -19.11 |
EPS (Diluted) | 32.11 | -6.12 | -8.45 | -19.37 | -15.21 | -19.11 |
EBITDA | 616.77M | -361.24M | -738.16M | -1.89B | -1.39B | -1.63B |
EBIT | 475.09M | -533M | -825.84M | -1.96B | -1.44B | -1.66B |
Depreciation & Amortization | 141.69M | 171.76M | 87.68M | 66.28M | 46.46M | 31.79M |
Add to Watchlist
Select watchlists to add or remove ONC